These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 2877832)
1. N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice. Hultin TA; May CM; Moon RC Drug Metab Dispos; 1986; 14(6):714-7. PubMed ID: 2877832 [TBL] [Abstract][Full Text] [Related]
2. Distribution and metabolism of the retinoid, N-(4-methoxyphenyl)-all-trans-retinamide, the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice. Hultin TA; Filla MS; McCormick DL Drug Metab Dispos; 1990; 18(2):175-9. PubMed ID: 1971569 [TBL] [Abstract][Full Text] [Related]
3. Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice. Hultin TA; McCormick DL; May CM; Moon RC Drug Metab Dispos; 1988; 16(6):783-8. PubMed ID: 2907453 [TBL] [Abstract][Full Text] [Related]
4. Liquid chromatography method for quantifying N-(4-hydroxyphenyl)retinamide and N-(4-methoxyphenyl)retinamide in tissues. Vratilova J; Frgala T; Maurer BJ; Patrick Reynolds C J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 808(2):125-30. PubMed ID: 15261805 [TBL] [Abstract][Full Text] [Related]
5. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents. Swanson BN; Newton DL; Roller PP; Sporn MB J Pharmacol Exp Ther; 1981 Dec; 219(3):632-7. PubMed ID: 6170750 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of N-(4-hydroxyphenyl)-all-trans-retinamide in rats. Swanson BN; Zaharevitz DW; Sporn MB Drug Metab Dispos; 1980; 8(3):168-72. PubMed ID: 6104581 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture. Mehta RG; Hultin TA; Moon RC Biochem J; 1988 Dec; 256(2):579-84. PubMed ID: 2851995 [TBL] [Abstract][Full Text] [Related]
9. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy. McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843 [TBL] [Abstract][Full Text] [Related]
10. Effects of N-(4-hydroxyphenyl)retinamide supplementation on vitamin A metabolism. Lewis KC; Zech LA; Phang JM Cancer Res; 1994 Aug; 54(15):4112-7. PubMed ID: 8033144 [TBL] [Abstract][Full Text] [Related]
11. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide. Sabichi AL; Modiano MR; Lee JJ; Peng YM; Xu MJ; Villar H; Dalton WS; Lippman SM Clin Cancer Res; 2003 Jul; 9(7):2400-5. PubMed ID: 12855611 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1. Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568 [TBL] [Abstract][Full Text] [Related]
13. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide. Lewis KC; Hochadel JF Cancer Res; 1999 Dec; 59(23):5947-55. PubMed ID: 10606240 [TBL] [Abstract][Full Text] [Related]
14. Comparative activity of dietary or topical exposure to three retinoids in the promotion of skin tumor induction in mice. McCormick DL; Bagg BJ; Hultin TA Cancer Res; 1987 Nov; 47(22):5989-93. PubMed ID: 2959358 [TBL] [Abstract][Full Text] [Related]
18. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor. Moon RC; Pritchard JF; Mehta RG; Nomides CT; Thomas CF; Dinger NM Carcinogenesis; 1989 Sep; 10(9):1645-9. PubMed ID: 2527636 [TBL] [Abstract][Full Text] [Related]
19. Disposition of 13-cis-retinoic acid and N-(2-hydroxyethyl)retinamide in mice after oral doses. Kalin JR; Wells MJ; Hill DL Drug Metab Dispos; 1982; 10(4):391-8. PubMed ID: 6126340 [TBL] [Abstract][Full Text] [Related]
20. Subacute toxicity of all-trans- and 13-cis-isomers of N-ethyl retinamide, N-2-hydroxyethyl retinamide, and N-4-hydroxyphenyl retinamide. Sani BP; Meeks RG Toxicol Appl Pharmacol; 1983 Sep; 70(2):228-35. PubMed ID: 6226123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]